Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

apalutamide

(A-puh-LOO-tuh-mide)
A drug used to treat prostate cancer that has spread to other parts of the body and is castration sensitive (has responded to treatments that lower testosterone levels) and prostate cancer that has not spread to other parts of the body and is castration resistant (has not responded to treatments that lower testosterone levels). Apalutamide binds to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and may cause cancer cells to grow. Apalutamide blocks these proteins and may keep cancer cells from growing. It is a type of antiandrogen. Also called Erleada.
Search NCI's Dictionary of Cancer Terms